8716
W.-J. Shi et al. / Tetrahedron 68 (2012) 8712e8718
J¼16.8 Hz, 1H, CH]CH), 7.57 (d, J¼8.4 Hz, 2H, ArH), 7.53 (d,
J¼16.8 Hz, 1H, CH]CH), 7.13 (d, J¼8.4 Hz, 2H, ArH), 7.02 (d,
J¼8.4 Hz, 2H, ArH), 6.91 (d, J¼8.4 Hz, 2H, ArH), 3.98e4.04 (m, 4H,
CH2), 2.68 (s, 3H, CH3), 1.76e1.86 (m, 4H, CH2), 1.50 (s, 3H, CH3), 1.46
(s, 3H, CH3), 1.46e1.50 (m, 4H, CH2), 1.28 (br s, 32H, CH2), 0.87e0.90
7.37 (d, J¼8.8 Hz, 2H, ArH), 7.15 (d, J¼8.8 Hz, 2H, ArH), 7.01 (d,
J¼8.8 Hz, 2H, ArH), 6.90 (d, J¼8.4 Hz, 2H, ArH), 6.67 (d, J¼8.8 Hz, 2H,
ArH), 3.98e4.04 (m, 4H, CH2), 3.00 (s, 6H, CH3), 2.69 (s, 3H, CH3),
1.76e1.87 (m, 4H, CH2), 1.60 (s, 3H, CH3), 1.42e1.54 (m, 7H, CH2 and
CH3), 1.28 (br s, 32H, CH2), 0.87e0.91 (m, 6H, CH3). 13C{1H} NMR:
(m, 6H, CH3). 13C{1H} NMR:
d
160.5, 160.3, 156.5, 150.7, 146.4, 145.0,
d 160.5, 160.1, 154.8, 153.3, 150.3, 145.6, 143.3, 140.2, 139.6, 132.5,
140.4, 139.2, 132.8, 132.4, 129.4, 129.3, 126.9, 116.6, 115.5, 115.0, 86.0,
82.3, 68.4, 68.3, 32.1, 29.8, 29.7, 29.6, 29.5, 29.4, 26.2, 22.9, 17.8, 17.3,
16.3, 14.3 (some of the signals are overlapped). MS (ESI): m/z 1032
(100%, [M]þ). HRMS (ESI): m/z calcd for C50H69BF2I2N2O2 [M]þ:
1032.3512, found 1032.3511. Anal. Calcd for C50H69BF2I2N2O2: C,
58.15; H, 6.73; N, 2.71. Found: C, 58.13; H, 6.73; N, 2.27.
132.3, 129.7, 129.5, 129.4, 126.9, 116.7, 115.3, 115.0, 112.1, 110.3, 99.7,
85.0, 81.7, 68.4, 68.3, 40.4, 32.1, 29.8, 29.7, 29.6, 29.5, 29.4, 26.2, 22.8,
17.1, 16.1, 14.3, 13.7 (some of the signals are overlapped). MS (ESI):
m/z 1051 (100%, [MþH]þ). HRMS (ESI): m/z calcd for
C60H80BF2IN3O2 [MþH]þ: 1050.5351, found 1050.5351. Anal. Calcd
for C60H79BF2IN3O2: C, 68.63; H, 7.58; N, 4.00. Found: C, 68.57; H,
7.81; N, 3.72. Compound 8: 1H NMR:
d
8.08 (d, J¼16.4 Hz, 1H, CH]
4.3. Distyryl BODIPY 4
CH), 7.58 (d, J¼8.8 Hz, 2H ArH), 7.54 (d, J¼16.4 Hz,1H, CH]CH), 7.34
(d, J¼8.8 Hz, 2H, ArH), 7.15 (d, J¼8.4 Hz, 2H, ArH), 7.02 (d, J¼8.4 Hz,
2H, ArH), 6.91 (d, J¼8.8 Hz, 2H, ArH), 6.63 (d, J¼8.8 Hz, 2H, ArH),
3.98e4.04 (m, 4H, CH2), 2.98 (s, 6H, CH3), 2.74 (s, 3H, CH3),
1.76e1.87 (m, 4H, CH2), 1.56 (s, 3H, CH3), 1.51 (s, 3H, CH3), 1.42e1.49
(m, 4H, CH2), 1.28 (br s, 32H, CH2), 0.87e0.91 (m, 6H, CH3). 13C{1H}
According to the above procedure, BODIPY
1 (100 mg,
0.13 mmol) was treated with benzaldehyde 2 (153 mg, 0.53 mmol),
piperidine (1.2 mL), acetic acid (1.0 mL), and a small amount of
Mg(ClO4)2 in refluxing toluene (40 mL) for 1.5 h to give 4, which
was purified by column chromatography with CH2Cl2/hexane (2:3,
v/v) as the eluent followed by size exclusion chromatography with
NMR:
d 160.3, 160.1, 159.2, 150.2, 150.1, 149.8, 145.0, 143.7, 140.6,
138.3, 133.1, 132.6, 132.1, 129.6, 129.5, 129.2, 126.9, 117.9, 116.7, 115.4,
114.9, 112.1, 112.0, 110.4. 110.3, 98.1, 81.6, 79.5, 79.4, 68.4, 68.3, 40.4,
32.1, 29.8, 29.7, 29.6, 29.5, 29.4, 26.2, 22.9, 17.6, 14.3, 14.1, 13.9 (some
of the signals are overlapped). MS (ESI): m/z 1051 (100%, [MþH]þ).
HRMS (ESI): m/z calcd for C60H80BF2IN3O2 [MþH]þ: 1050.5351,
found 1050.5362. Anal. Calcd for C60H79BF2IN3O2: C, 68.63; H, 7.58;
N, 4.00. Found: C, 67.85; H, 7.60; N, 3.99.
THF as the eluent (83.7 mg, 49%). 1H NMR:
d
8.13 (d, J¼16.8 Hz, 2H,
CH]CH), 7.60 (d, J¼8.8 Hz, 4H, ArH), 7.59 (d, J¼16.8 Hz, 2H, CH]
CH), 7.15 (d, J¼8.8 Hz, 2H, ArH), 7.03 (d, J¼8.8 Hz, 2H, ArH), 6.94 (d,
J¼8.8 Hz, 4H, ArH), 3.99e4.05 (m, 6H, CH2), 1.77e1.86 (m, 6H, CH2),
1.55 (s, 3H, CH3), 1.51 (s, 3H, CH3), 1.42e1.51 (m, 6H, CH2), 1.28 (br s,
48H, CH2), 0.87e0.90 (m, 9H, CH3). 13C{1H} NMR:
d 160.5 160.3,
150.5, 145.8, 139.2, 138.8, 133.4, 129.7, 129.6, 129.4, 127.2, 116.8,
115.5, 115.0, 82.7, 68.4, 68.3, 32.1, 29.8, 29.7, 29.6, 29.5, 29.4, 26.2,
22.9, 17.9, 14.3 (some of the signals are overlapped). MS (ESI): m/z
1305 (100%, [M]þ). HRMS (ESI): m/z calcd for C69H97BF2I2N2O3
[M]þ: 1304.5644, found 1304.5642.
4.6. Distyryl BODIPY 9
According to the procedure described for 6, distyryl BODIPY 4
(201 mg, 0.15 mmol) was treated with PdCl2(PPh3)2 (5.2 mg,
7.4 mmol), CuI (3.0 mg, 15.8 mmol), alkyne 5 (33.4 mg, 0.23 mmol),
4.4. BODIPY 6
and DIEA (4 mL) in THF (10 mL) at room temperature for 12 h to
give 9, which was purified by column chromatography using
CH2Cl2/hexane (1:1 to 3:1, v/v) as the eluent (87.3 mg, 43%). 1H
A mixture of BODIPY 1 (301 mg, 0.40 mmol), PdCl2(PPh3)2
(14.4 mg, 20.5
m
mol), CuI (7.6 mg, 40
m
mol), 4-(dimethylamino)
NMR:
d
8.53 (d, J¼16.4 Hz, 1H, CH]CH), 8.09 (d, J¼16.4 Hz, 1H,
phenylethyne (5) (63.4 mg, 0.44 mmol), and DIEA (5 mL) in THF
(10 mL) was stirred at room temperature for 12 h. The volatiles were
removed in vacuo, then the dark purple residue was subjected to
column chromatography using CH2Cl2/hexane (1:1 to 3:2, v/v) as the
eluent. The product was collected as a dark purple solid (102 mg,
CH]CH), 7.71 (d, J¼16.4 Hz, 1H, CH]CH), 7.58e7.63 (m, 5H, ArH
and CH]CH), 7.37 (d, J¼8.8 Hz, 2H, ArH), 7.17 (d, J¼8.4 Hz, 2H, ArH),
7.02 (d, J¼8.8 Hz, 2H, ArH), 6.95 (d, J¼8.8 Hz, 2H, ArH), 6.92 (d,
J¼8.4 Hz, 2H, ArH), 6.67 (d, J¼8.8 Hz, 2H, ArH), 3.99e4.04 (m, 6H,
CH2), 3.00 (s, 6H, CH3), 1.77e1.88 (m, 6H, CH2), 1.60 (s, 3H, CH3), 1.51
(s, 3H, CH3), 1.42e1.50 (m, 6H, CH2), 1.28 (br s, 48H, CH2), 0.87e0.90
33%). 1H NMR:
d
7.33 (d, J¼8.8 Hz, 2H, ArH), 7.13 (d, J¼8.8 Hz, 2H,
ArH), 7.02 (d, J¼8.8 Hz, 2H, ArH), 6.63 (d, J¼8.8 Hz, 2H, ArH), 4.02 (t,
J¼6.8 Hz, 2H, CH2), 2.98 (s, 6H, CH3), 2.70 (s, 3H, CH3), 2.64 (s, 3H,
CH3), 1.84 (quintet, J¼6.8 Hz, 2H, CH2), 1.56 (s, 3H, CH3), 1.44e1.54
(m, 2H, CH2),1.46 (s, 3H, CH3),1.28 (br s,16H, CH2), 0.87e0.90 (m, 3H,
(m, 9H, CH3). 13C{1H} NMR:
d 160.5, 160.2, 160.1, 153.3, 150.2, 149.2,
145.1, 144.2, 139.7, 138.6, 138.0, 133.5, 133.2, 132.3, 129.8, 129.5,
129.2, 127.2, 117.0, 115.3, 115.0, 114.9, 112.1, 110.4, 99.9, 81.8, 68.4,
68.3, 40.3, 32.1, 29.8, 29.7, 29.6, 29.5, 29.4, 26.2, 22.8, 17.6, 14.3, 13.7
(some of the signals are overlapped). MS (ESI): m/z 1323 (100%,
[MþH]þ). HRMS (ESI): m/z calcd for C79H108BF2IN3O3 [MþH]þ:
1322.7491, found 1322.7496. Anal. Calcd for C79H107BF2IN3O3: C,
71.75; H, 8.16; N, 3.18. Found: C, 71.49; H, 8.12; N, 2.92.
CH3). 13C{1H} NMR:
d 160.2, 159.2, 155.4, 150.2, 144.3, 144.1, 142.0,
132.6, 132.2, 131.5, 129.3 126.6, 117.6, 115.4, 112.0, 110.3, 97.9, 84.8,
79.3, 68.4, 40.4, 32.1, 29.8, 29.7, 29.6, 29.5, 29.4, 26.2, 22.8, 17.1, 16.0,
14.3, 13.9 (some of the signals are overlapped). MS (ESI): m/z 778
(100%, [MþH]þ). HRMS (ESI): m/z calcd for C41H52BF2IN3O [MþH]þ
778.3218, found 778.3224. Anal. Calcd for C41H51BF2IN3O: C, 63.33;
H, 6.61; N, 5.40. Found: C, 63.04; H, 6.67; N, 5.13.
4.7. BODIPY 11
A mixture of compound 6 (50.0 mg, 64.3
mmol), PdCl2(PPh3)2
4.5. Monostyryl BODIPY 7 and 8
(2.3 mg, 3.3 mol), CuI (1.4 mg, 7.4 mol), 4-nitrophenylethyne (10)
m
m
(18.9 mg, 0.13 mmol), and DIEA (2 mL) in THF (4 mL) was refluxed
for 12 h. The volatiles were removed in vacuo, then the dark blue
residue was chromatographed using CH2Cl2/hexane (3:2 to 2:1, v/v)
as the eluent. The product was collected as a dark blue solid
According to the procedure described for 6, monostyryl BODIPY
3 (200 mg, 0.19 mmol) was treated with PdCl2(PPh3)2 (6.8 mg,
9.7 mmol), CuI (3.7 mg, 19.4 mmol), alkyne 5 (28.2 mg, 0.19 mmol),
and DIEA (5 mL) in THF (10 mL) at room temperature for 12 h. The
crude product was purified by column chromatography using
CH2Cl2/hexane (1:1 to 3:2, v/v) as the eluent. The first two blue
bands were collected to give 7 (37.2 mg, 18%) and 8 (45.3 mg, 22%),
(40.4 mg, 79%). 1H NMR:
d
8.18 (d, J¼8.8 Hz, 2H, ArH), 7.55 (d,
J¼8.8 Hz, 2H, ArH), 7.33 (d, J¼8.8 Hz, 2H, ArH), 7.17 (d, J¼8.8 Hz, 2H,
ArH), 7.04 (d, J¼8.8 Hz, 2H, ArH), 6.63 (d, J¼8.8 Hz, 2H, ArH), 4.03 (t,
J¼6.4 Hz, 2H, OCH2), 2.98 (s, 6H, CH3), 2.72 (s, 3H, CH3), 2.71 (s, 3H,
CH3), 1.84 (quintet, J¼6.4 Hz, 2H, CH2), 1.58 (s, 6H, CH3), 1.46e1.54
(m, 2H, CH2), 1.33e1.43 (m, 2H, CH2), 1.28 (br s, 14H, CH2),
respectively. Compound 7: 1H NMR:
CH), 7.65 (d, J¼16.4 Hz, 1H, CH]CH), 7.58 (d, J¼8.4 Hz, 2H, ArH),
d
8.50 (d, J¼16.4 Hz, 1H, CH]